castrate-resistant prostate cancer
Showing 1 - 25 of >10,000
Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (Sipuleucel-T Injection)
Not yet recruiting
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Sipuleucel-T Injection
- (no location specified)
Nov 10, 2023
Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Trial (TmPSMA-02 CAR T Cells)
Not yet recruiting
- Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
- TmPSMA-02 CAR T Cells
- (no location specified)
Sep 13, 2023
Castrate-Resistant Prostate Cancer Trial in Shanghai (LIGHT-PSMA-CART cells)
Suspended
- Castrate-Resistant Prostate Cancer
- LIGHT-PSMA-CART cells
-
Shanghai, Shanghai, ChinaChanghai Hospital
Jan 25, 2023
Metastasis Castration Resistant Prostate Cancer(mCRPC) Trial (HS-20093)
Not yet recruiting
- Metastasis Castration Resistant Prostate Cancer(mCRPC)
- (no location specified)
Aug 14, 2023
Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial ([177Lu]Lu-PSMA-617, ARDT, [68Ga]Ga-PSMA-11)
Not yet recruiting
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- [177Lu]Lu-PSMA-617
- +3 more
- (no location specified)
Jan 23, 2023
Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in San Francisco
Not yet recruiting
- Castrate Resistant Prostate Cancer
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Mar 1, 2023
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Detroit,
Active, not recruiting
- Castration Levels of Testosterone
- +4 more
-
Detroit, Michigan
- +1 more
Aug 30, 2022
Prostatic Tumors, Castration-Resistant Trial (64Cu-SAR-BBN, 67Cu-SAR-BBN)
Not yet recruiting
- Prostatic Neoplasms
- Castration-Resistant
- (no location specified)
Dec 1, 2022
Metastatic Castrate-resistant Prostate Cancer, mCRPC Trial in Dallas (Sipuleucel-T, Stereotactic Ablative Body Radiation)
Completed
- Metastatic Castrate-resistant Prostate Cancer
- mCRPC
- Sipuleucel-T
- Stereotactic Ablative Body Radiation
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Apr 11, 2022
Castrate-Resistant Prostate Cancer Trial in Hangzhou (PD1-PSMA-CART cells)
Recruiting
- Castrate-Resistant Prostate Cancer
- PD1-PSMA-CART cells
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University
Feb 26, 2022
Prostate Cancer Trial in Philadelphia (CART-PSMA-TGFßRDN cells, Cyclophosphamide, Fludarabine)
Recruiting
- Prostate Cancer
- CART-PSMA-TGFβRDN cells
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Mar 17, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San
Recruiting
- Castration-Resistant Prostate Carcinoma
- +6 more
- Abemaciclib
- Lutetium Lu 177-PSMA-617
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 8, 2022
Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer Trial in
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- +2 more
- 177Lu HTK03170
- 68Ga-HTK03149
-
Vancouver, British Columbia, CanadaBC Cancer
Nov 28, 2022
Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Baltimore
Recruiting
- Prostate Cancer
- +2 more
- Testosterone Undecanoate
- Enzalutamide
-
Baltimore, MarylandJohns Hopkins Hospital
May 6, 2022
Prostate Cancer, Castrate Resistant Prostate Cancer Trial (Enzalutamide 40 MG, Docetaxel injection)
Not yet recruiting
- Prostate Cancer
- Castrate Resistant Prostate Cancer
- Enzalutamide 40 MG
- Docetaxel injection
- (no location specified)
Jan 27, 2023
Drug-drug Interactions in Patients Treated With Anticancer
Recruiting
- Prostatic Neoplasm
- data collection
-
Besançon, FranceCentre Hospitalier Universitaire de Besançon
Nov 9, 2022
Prostate Cancer Trial in Houston (Alpharadin)
Completed
- Prostate Cancer
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 16, 2022
Melanoma, Prostate Cancer, Renal Cancer Trial in Providence (Naltrexone)
Terminated
- Melanoma
- +2 more
-
Providence, Rhode IslandMiriam Hospital
Feb 23, 2022
Dual Energy CT (DECT), Prostate Cancer Trial in Durham (Dual Energy Computed Tomography)
Terminated
- Dual Energy CT (DECT)
- Prostate Cancer
- Dual Energy Computed Tomography
-
Durham, North CarolinaDuke University Hospital
Jan 27, 2022
Prostate Cancer, Metastatic Castrate-Resistant Prostate Cancer, PSA Trial in Canada, United States (OGX-427, Abiraterone
Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Herlev
Recruiting
- Prostate Cancer Metastatic
- +3 more
- Stereotactic body radiotherapy
- +3 more
-
Herlev, Capital Region, DenmarkDepartment of Oncology, Copenhagen University Hospital Herlev an
Dec 16, 2022
Prostatic Tumors, Castration-Resistant Trial in United States (64Cu-SAR-bisPSMA, 67Cu-SAR-bisPSMA)
Recruiting
- Prostatic Neoplasms, Castration-Resistant
-
Phoenix, Arizona
- +6 more
May 23, 2022